|
Posted |
Poster |
Post |
|---|
| Thu 14:19 | fgnoms | Stretching the announcement of the results to the last possible date just in case something crops up is par for the course for PRM. The results aren't going to be pretty reading that's for sure. Another £4-5m loss no doubt - no cash - no contracts - no AD1000 data - no Randox news - just a load of imminence yet again. For the self proclaimed world leader in all things proteomic it jus... read more... |
| yesterday 16:50 | prambigear | The avatar Golly Blackwell is taking a well-earned leisure break in the sun Wileyson. I believe that he has occasional access to the free BB but probably believes that PRM will still be waiting for him on his return and so doesn't bother himself to post here. read more... |
| Wed 22:27 | hypochondriac | Muttlys point is clear to see Monte. Sad that you are so blind to it. read more... |
| yesterday 08:21 | mashman | Whoosh read more... |
| yesterday 10:55 | chutes01 | will we witness increased purchasing throughout the afternoon read more... |
| yesterday 07:18 | dafad | Merck/serono/quinties tie up http://www.pharmatimes.com/Article/13-05-16/Quintiles_inks_five-year_clinical_development_partnership_with_Merck_Serono.aspx read more... |
| Thu 11:18 | bluemango | Delayed buy of 41k from 08:11 this morning, just reported now after the uptick to look like a sell. read more... |
| Wed 21:23 | muttlly | Teh Cabal Guide to teh Other Universe - POS
monte1 - 09 Jan 2013 - 08:20:07 - 3701 of 7239
Morning all.
Off topic I am currently shorting a British Bank like a Spaniard. read more... |
| 12 May 2013 | alchemy | that could help to identify dementia in the pre- clinical phase, or to predict the progression from mild cognitive impairment to dementia.
the pre clinical IS there ..could has become ..can .....and one day it might ... read more... |
| 12 May 2013 | bluemango | There's more.
Having had a chance to look at this more closely, the opening sentences are new, and I've emphasised in bold what I believe to form the main update:
"Preliminary data generated by the NIHR Maudsley BRC and Proteome Sciences suggest that proteins in blood may act as biomarkers that could help to identify dementia in the pre-clinical phase, or to predict the progression from mild... read more... |
18/05/2013 08:44:33
